Product details

OZURDEX

OZURDEX is indicated for the treatment of adult patients with macular oedema following either Branch Retinal Vein Occlusion (BRVO) or Central Retinal Vein Occlusion (CRVO) and is also indicated for the treatment of adult patients with inflammation of the posterior segment of the eye presenting as non-infectious uveitis and visual impairment due to diabetic macular oedema (DME) who are pseudophakic or who are considered insufficiently responsive to, or unsuitable for non-corticosteroid therapy.
With Prescription
  • Group

    Eye Care

  • Product Subgroup

    Retinal Disease

  • Composition

    dexamethasone 700mcg intravitreal implant